Good MorningThe broad S&P 500 index advanced another 2.0% on Thursday bringing the rally to four days. The move is seemingly inexplicable with so much uncertainty in the air but may come down to one thing. Where the market is concerned, a Biden victory and Republican senate is the best-case scenario for the economy. With this outcome, it is all but assured there will be no major changes at the Federal level until after the mid-term election cycle at least.
In other news, the FOMC decided to hold interest unchanged and made no move to alter existing stimulus efforts. Fed Cheif Jerome Powell says the economy is rebounding but still well below the pre-COVID levels. He says the committee is closely watching the data and is prepared to act if needed. In his word, the Fed is not out of ammunition yet.
Featured: Historic Refi Rate: 2.28% APR (15 year) (LendingTree) 
|
Tech | | | Technology and health care companies led a stock market rally Wednesday, as Wall Street embraced the upside of more gridlock in Washington even as the outcome of the U.S. presidential election remained in limbo.
The S&P 500 rose 2.2% for its best day in five months. The benchmark... Read the Full Story |
|
|
Stocks | | |
There’s been a change in character in the market lately, with many of the high-flying technology stocks that have rallied for the majority of the year experiencing heavy selling. Investors are likely profit-taking after a massive run in some of the hottest sectors, and it’s interesting... Read the Full Story |
|
Stocks | | | it appears that ridesharing, sports betting, and cannabis companies might be in for some upside going forward. 3 stocks in those respective industries look like solid buys at this time. Let’s take a deeper look at them below. Read the Full Story |
|
|
Markets | | | Chinese leaders are conducting an import fair under intensive anti-coronavirus controls in their latest effort to revive the world’s No. 2 economy while the United States and Europe struggle with a renewed surge of infections Read the Full Story |
|
Tech | | | App-based companies like Uber, Lyft and Doordash have dodged a potentially devastating blow to their industry by carving out an exemption from a California law that required them to classify their drivers as employees instead of contractors Read the Full Story |
|
From Our PartnersLendingTree has helped over 1.1 million Americans with refinancing. Calculate your payment to see how much you can save. | | | | Continue Reading |
|
Markets | | | Nintendo, the Japanese company behind Super Mario and Pokemon video games, reported Thursday that its fiscal first half profit more than tripled as passed time while stuck at home during the pandemic playing games.
Kyoto-based Nintendo Co.’s profit for the six months through Septembe... Read the Full Story |
|
Politics | | | Sri Lankan authorities will end a pandemic curfew imposed in parts of the country, saying people themselves should take the responsibility to avoid being infected the new coronavirus.
Army Commander Shavendra Silva heads a COVID-19 task force and he says President Gotabaya Rajapaksa i... Read the Full Story |
|
Markets | | | Another Blow-Out Quarter For Scotts-Miracle Grow
Scotts-Miracle Grow (NYSE:SMG) emerged as a winner early in the pandemic and is one rebound story that has legs. This company is not only producing strong double-digit growth that growth accelerated in the 4th quarter and more is expected for next ye... Read the Full Story |
|
Markets | | | A Specialty Dividend For Dividend Growth Investors
I am well aware of the trends within the consumer food group so I am not surprised by what I see in Lancaster Colony Corporation’s (NASDAQ:LANC) fiscal Q1 report. What I am surprised about is that I have never heard of this company and I wish... Read the Full Story |
|
Markets | | | Cardinal Health Pops After Q3 Earnings
I like Cardinal Health (NYSE:CAH) for many reasons but there are a few that stand out. The first is that Cardinal Health is a great dividend-payer in the health care field. The second is that Cardinal Health is part of what I like to call the infrastructure of... Read the Full Story |
|
The Early Bird Stock Of The Day ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado. | | View Today's Stock Pick |
|
